Researchers from the Medical University of Bialystok, Poland, have used metabolomics and liquid chromatography quadrupole time‑of‑flight mass spectrometry (LC–QTOF‑MS) to study human ocular fluids.
Photo Credit: photoJS/Shutterstock.com
Researchers from the Medical University of Bialystok, Poland, have used metabolomics and liquid chromatography quadrupole timeâofâflight mass spectrometry (LC–QTOFâMS) to study human ocular fluids (1).
Severely debilitating and often devastating for life quality, eye diseases such as cataracts, glaucoma, diabetic retinopathy, or ageârelated macular degeneration affect millions globally with numbers expected to increase in the following decades. In the US alone, the National Eye Institute estimates the number of people affected by the most common eye diseases will double by 2050 (2), however, aqueous humor (AH), the transparent fluid responsible for supplying nutrients and removing metabolic waste from avascular tissues in the eye, is one of the least explored human fluids by modern metabolomic techniques. This is despite the huge potential for studying human AH with metabolomics, which could offer increased understanding of the mechanisms at play during disease development and even indicate promising metabolic pathways for drug targets.
Currently, only a few studies have applied metabolomics to AH (3–7) with most using animal models and favouring the use of nuclear magnetic resonance spectroscopy (NMR). The current study aimed to develop a strategy for the extraction of metabolites from AH and their analysis by LC–QTOF-MS for the detection of the highest number of metabolites by a single analytical platform.
Researchers tested multiple protocols for AH sample preparation before metabolic fingerprinting analysis with the best results obtained with a mixture of methanol:ethanol (1:1). Diluting the AH samples twice, 2 μL of extracted sample was analyzed using reversed phase chromatography with QTOFâMS detection, identifying over 1000 metabolic features from which almost 250 were identified putatively and the identify of over 50 were confirmed by MS/MS fragmentation. These initial results hint towards a greater than previously thought role for amino acids, lipids, oxidative stress, and microbial metabolites in the development of eye diseases, but more research is required. - L.B.
References
HPLC 2025 Preview: The Present and Future of Automation in Analytical Laboratories
May 22nd 2025Analytical laboratories are undergoing a fundamental transformation. In the face of increasing sample volumes, growing regulatory requirements, and the rising demand for faster, more precise, and cost-efficient analysis, optimizing laboratory processes is becoming a central focus. Automation technologies offer promising solutions in this regard. Recently, they have evolved from isolated solutions to comprehensive systems that permeate nearly all areas of laboratory practice. This development not only opens up new opportunities in terms of efficiency, data quality, and scalability but also brings technical, organizational, and personnel challenges. To successfully address these, strategic approaches are needed that consider both the technological and human dimensions of the transformation.
Quantifying Isavuconazole in Dried Blood Spots Using HPLC
May 21st 2025Isavuconazole, an antimycotic agent used to treat fungal infections, can typically be found during dried blood spot sampling. However, there are obstacles that keep it from being an ideal approach for properly determining the drug’s presence.
Separating and Quantifying Spinach Flavonoids with UHPLC–MS/MS
May 21st 2025Researchers at Baylor College of Medicine’s Children's Nutrition Research Center (Houston, Texas) developed and validated a high-throughput extraction and ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) method to separate and quantify 39 spinach flavonoid species in 11.5 min.